Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS

Stoppel Laura received 35,500 Acumen Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 3, 2026 · Filed Jun 5, 2026

On Jun 3, 2026, Stoppel Laura (Director) received 35,500 Acumen Pharmaceuticals, Inc. shares as an award, leaving 48,300 shares. Filed Jun 5, 2026 (Form 4).

Awarded
35,500 shares
Holding after
48,300 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 3, 2026Common StockAward35,50048,300Direct

Source

View original at SEC

Related